← TrialMatch
HomeTrials

Gut Microbiota of Preterm Infants and Full-term Infants at Early Life

The aim of this study is to obtain a longitudinal view of the gut microbial establishment of a cohort of 51 preterm (PT) infants compared to 50 full-term (FT) infants from birth to 90 days of age, and to identify key clinical factors that affect the establishment of neonatal microbiome. The hypothesis of the investigat

Condition(s)Preterm Infant, Gut Microbiome
StatusRecruiting
Study typeObservational
SummaryThe aim of this study is to obtain a longitudinal view of the gut microbial establishment of a cohort of 51 preterm (PT) infants compared to 50 full-term (FT) infants from birth to 90 days of age, and to identify key clinical factors that affect the establishment of neonatal microbiome. The hypothesis of the investigators is that the gut microbiota progression of PT group and FT group is different in diversity and composition. Antibiotics and its usage duration is likely the main factor disturbing the colonization and development of the gut microbiome of PT infants.
Who can participateInclusion Criteria: Preterm infants 1. gestational age \<37 weeks; 2. no gastrointestinal tract disorders, metabolic diseases, or viral hepatitis; 3. hospital stay \> 7 days; Exclusion criteria: 1. NICU stay less than 7 days 2. Necrotizing enterocolitis infant Control group: 1. Full-term healthy infants; 2. gestational age \>37 weeks; 3. vaginally born; 4. no gastrointestinal tract disorders, metabolic diseases, or viral hepatitis.
Ages1 Day to 4 Months
SexAll
Accepts healthy volunteersYes
Lead sponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
LocationsShanghai, China
Start date2014-07-20
NCT IDNCT03373721
Official listinghttps://clinicaltrials.gov/study/NCT03373721

🔍 Search all trials →